While technology stocks sold off on October 30, 2026, healthcare earnings told a very different story. Regeneron surged 13.33% to $927.89 after a third-quarter report that beat expectations by a wide margin, and AbbVie raised its full-year profit forecast after topping estimates, with its shares closing up 1.41% at $294.89, a record. Colgate-Palmolive also rose 2.29% to $95.29 after raising its...
